The DOI matches its Crossref record.
Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children: Treatment of morphoea in children
Abstract
BACKGROUND: Localized scleroderma (LS) or morphoea is often considered to be a benign self-limiting condition confined to the skin and subcutaneous tissue. However, the course of the disease is unpredictable and severe functional and cosmetic disability may result. Drug treatment with systemic corticosteroids in combination with methotrexate has been reported to be beneficial in LS, but data in children is limited. OBJECTIVES: To evaluate the efficacy and tolerability of systemic corticosteroids in combination with methotrexate in children with LS. METHODS: Treatment and outcome of 34 patients with LS were retrospectively analysed. Pulsed intravenous methylprednisolone was given, followed by oral prednisolone on a reducing regimen and maintenance treatment with methotrexate. We assessed treatment outcome clinically and by thermography and monitored adverse events. RESULTS: From the onset of treatment, the disease stopped progressing in 94% of the patients. All patients demonstrated significant clinical improvement within a mean time of 5.7 +/- 3.9 months. Mean duration of follow-up over the treatment period and beyond was 2.9 +/- 2.0 years. In 16 (47%) patients therapy was discontinued when the disease was considered to be inactive clinically; however, seven (44%) of the 16 developed a relapse, necessitating repeat treatment. At last follow-up (range 0.2-7.0 years), 24 (71%) of the 34 patients had completely inactive disease. Observed adverse events were moderate and transient and no patient had to stop therapy. CONCLUSIONS: These data suggest that systemic corticosteroids and methotrexate in combination are beneficial and well tolerated in the treatment of children with LS. Because of the risk of relapse after discontinuing therapy, long-term monitoring is mandatory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fett, N., & Werth, V. P. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.05.045 · Cited by 394
Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14458 · Cited by 261
Localized scleroderma: clinical spectrum and therapeutic update
Careta, M. F., & Romiti, R. (2015) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20152890 · Cited by 259
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
Ma, J., Li, W., Cao, R., Gao, D., Zhang, Q., Li, X., Li, B., Lv, L., Li, M., Jiang, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202106075 · Cited by 38
Metadata
- Authors
- Weibel, L., Sampaio, M. C., Visentin, M. T., Howell, K. J., Woo, P., & Harper, J. I.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-30
- Volume
- 155
- Issue
- 5
- Pages
- 1013-1020
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W2129989036
- Cited by
- 216
- References
- 0
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children: Treatment of morphoea in children. https://app.cochat.ai/papers/10.1111/j.1365-2133.2006.07497.x
- The paper
- Weibel, L., Sampaio, M. C., Visentin, M. T., Howell, K. J., Woo, P., & Harper, J. I. (2006). Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children: Treatment of morphoea in children. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2006.07497.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.